Cancers (Aug 2022)

T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell Cancer

  • Eike Burandt,
  • Niclas C. Blessin,
  • Ann-Christin Rolschewski,
  • Florian Lutz,
  • Tim Mandelkow,
  • Cheng Yang,
  • Elena Bady,
  • Viktor Reiswich,
  • Ronald Simon,
  • Guido Sauter,
  • Sven Mahner,
  • Nikolaus de Gregorio,
  • Rüdiger Klapdor,
  • Matthias Kalder,
  • Elena I. Braicu,
  • Sophie Fürst,
  • Maximilian Klar,
  • Hans-Georg Strauß,
  • Katharina Prieske,
  • Linn Wölber

DOI
https://doi.org/10.3390/cancers14174246
Journal volume & issue
Vol. 14, no. 17
p. 4246

Abstract

Read online

Background: Although quantification of tumor infiltrating lymphocytes (TILs) has become of increasing interest in immuno-oncology, only little is known about TILs infiltration in the tumor microenvironment and its predictive value in vulvar cancer. Methods: Immunohistochemistry and automated digital image analysis was applied to measure the densities of CD3+ (DAKO, #IR503) and CD8+ (DAKO, #IR623) TILs at the invasive margin and in the center of 530 vulvar squamous cell cancers. Results: An elevated density of CD3+ T-cell at the invasive margin was significantly associated with low tumor stage (p = 0.0012) and prolonged survival (overall survival [OS] p = 0.0027, progression free survival [PFS] p = 0.024) and was independent from tumor stage, nodal stage, grade, and HPV-status in multivariate analysis (p + cells in the center of the tumor was weaker compared to the invasive margin (OS p = 0.046, PFS p = 0.031) and lacking for CD8+ T-cell densities at any location (p ≥ 0.14 each). Unsupervised clustering of CD3+ and CD8+ T-cell densities identified three major subgroups corresponding to the immune desert (137 patients), immune excluded (220 patients) and immune inflamed phenotypes (133 patients). Survival analysis revealed a particular poor prognosis for the immune desert phenotype for OS (p = 0.0071) and PFS (p = 0.0027). Conclusion: Our data demonstrate a high prognostic value of CD3+ T-cells at the invasive margin and immune phenotypes in vulvar squamous cell cancer.

Keywords